Open AccessComparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes
Author(s) -
Garvan C. Kane,
Anthony W. Stanson,
Dita Kalnická,
David Rosenthal,
C. U. Lee,
Stephen C. Textor,
Vesna D. Garovic
Publication year - 2007
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfm725
Subject(s) - medicine , iodinated contrast , nephrogenic systemic fibrosis , iodixanol , gadolinium , gadodiamide , contrast induced nephropathy , iohexol , creatinine , nephropathy , kidney disease , renal function , renal artery stenosis , angiography , radiology , kidney , renal artery , percutaneous coronary intervention , contrast medium , magnetic resonance imaging , endocrinology , computed tomography , materials science , myocardial infarction , metallurgy , diabetes mellitus
Percutaneous angiography with iodinated contrast in patients with chronic kidney disease carries a risk of contrast nephropathy, which is independently associated with renal disease progression and increased mortality. Gadolinium contrast is a potential alternative to iodinated contrast for percutaneous transluminal renal angioplasty (PTRA), and appears to be safe and well tolerated. The aim of this study was to assess the results of gadolinium use to facilitate PTRA in patients with chronic kidney disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom